Toronto Dominion Bank
ALLO icon

Toronto Dominion Bank’s Allogene Therapeutics ALLO Stock Holding History

Toronto Dominion Bank’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27
Closed -$66 – 2294
2026
Q1 		$66 Hold
27
– – ﹤0.01% 2068
2025
Q4 		$37 Hold
27
– – ﹤0.01% 2044
2025
Q3 		$33 Hold
27
– – ﹤0.01% 1891
2025
Q2 		$31 Hold
27
– – ﹤0.01% 1770
2025
Q1 		$39 Hold
27
– – ﹤0.01% 1518
2024
Q4 		$58 Buy
+27
New +$67 ﹤0.01% 1507
2024
Q3 		– Sell
-27
Closed -$63 – 1158
2024
Q2 		$63 Hold
27
– – ﹤0.01% 1384
2024
Q1 		$121 Hold
27
– – ﹤0.01% 1317
2023
Q4 		$87 Hold
27
– – ﹤0.01% 1472
2023
Q3 		$86 Hold
27
– – ﹤0.01% 1690
2023
Q2 		$0 Hold
27
– – ﹤0.01% 1486
2023
Q1 		$0 Buy
+27
New +$173 ﹤0.01% 1423

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Toronto Dominion Bank's ALLO Position: Q2 2026 in Review

Toronto Dominion Bank sold out of Allogene Therapeutics (ALLO) in Q2 2026, closing a stake of 27 shares — an estimated $66 sold.

Toronto Dominion Bank first reported a position in ALLO in Q1 2023 and held it in 12 quarters. The position peaked at $121 in Q1 2024. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • Toronto Dominion Bank reported no remaining Allogene Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 27 Allogene Therapeutics shares in Q2 2026, an estimated $66.
  • Toronto Dominion Bank first reported a position in Allogene Therapeutics in Q1 2023 and held it in 12 quarters.
  • Toronto Dominion Bank's Allogene Therapeutics position peaked at $121 in Q1 2024.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.